22 Oct 2026, 08:39 IST
Molbio Diagnostics Limited
Motilal Oswal Financial Services Ltd. (MOFSL) · Buy · target 1,800
The report lists Molbio Diagnostics as a Focus Investment Idea with a Buy rating and 36% upside over a 1-year horizon.
From MOStMarketOutlook22102026, written by Motilal Oswal Financial Services Ltd. (MOFSL) and hosted by Investment Guru India. Orivam summarised it; the view is Motilal Oswal Financial Services Ltd. (MOFSL)'s, not Orivam's.
Open the original PDF on Investment Guru India →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.